跳至主要内容
临床试验/NCT01430650
NCT01430650已完成4 期

A Randomised Control Trial to Evaluate Efficacy and Safety of Two Different Protocols of Endometrial Priming for Embryo Transfer.

Parc de Salut Mar1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2010年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
140
试验地点
1
主要终点
Difference between day means in endometrial priming to achieve 7 mm.

研究概览

简要总结

The aim of this trial is compare two different endometrial priming protocols

  • women that receive oral estrogens
  • women that receive transdermal estrogens

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women between 18-50 years old with desire of children and needs of embryo transfer.
  • Plasma prolactin less than
  • Uterine cavity that allow pregnancy, body mass index between 20-
  • And signed consent inform.

排除标准

  • History of estrogen dependent cancer, unknown origin vaginal bleeding.
  • Ovarian cyst.
  • Contraindications to be pregnant.
  • Estrogen allergy.

研究组 & 干预措施

Oral strogen

Experimental

干预措施: Oral strogen (Drug)

Transdermal strogen

Experimental

干预措施: Transdermal strogen (Drug)

结局指标

主要结局

Difference between day means in endometrial priming to achieve 7 mm.

时间窗: 11-16 days

次要结局

  • Biochemical Pregnancy rate(26-30 days)
  • The patient's adherence to the recommended treatment.(1-16 days)

研究者

发起方
Parc de Salut Mar
申办方类型
Other
责任方
Principal Investigator
主要研究者

Miguel Angel Checa

MD

Parc de Salut Mar

研究点 (1)

Loading locations...

相似试验